← Evidence map

ReviewJournal of hematology & oncology2017

Recent advances of highly selective CDK4/6 inhibitors in breast cancer.

Hanxiao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

81 papers cite itlatest 60 shown

2017
…
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28438180